Last Updated: May 11, 2026

Profile for Argentina Patent: 107965


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 107965

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Apr 25, 2026 Novartis ZYKADIA ceritinib
⤷  Start Trial Apr 29, 2028 Novartis ZYKADIA ceritinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Scope and Claims Analysis of Argentina Patent AR107965

Last updated: February 21, 2026

Overview of Patent AR107965

AR107965 pertains to a pharmaceutical composition related to a specific drug, with patent protection granted in Argentina. Its scope primarily involves the formulation, use, and manufacturing process of the active ingredient.

Patent Scope

The patent's scope covers:

  • A pharmaceutical composition containing a specified active ingredient, delivered in a particular dosage form.
  • Methods of manufacturing the composition.
  • Use of the composition for treating certain medical conditions.

AR107965's claims are directed toward narrow formulations and specific application methods, which influence its enforceability and licensing scope.

Claims Breakdown

Independent Claims

  • Focus on a pharmaceutical composition comprising a defined active ingredient at a set concentration.
  • Encompass the method of preparing the composition with steps outlined.

Dependent Claims

  • Specify variables such as excipient types, manufacturing conditions, and dosage forms.
  • Limit the scope to particular formulations like tablets or capsules.

Claim Language Analysis

Claims employ precise language but lack claims on broader therapeutic methods or alternative delivery systems, restricting broader enforcement.

Patent Landscape in Argentina

Patent Classification

AR107965 falls under the International Patent Classification (IPC) codes relevant to pharmaceuticals, notably:

  • A61K—Preparation for medical, dental, or cosmetic purposes.
  • C07D—Heterocyclic compounds.

Status of Patent Family

  • Patent AR107965 is part of a family with equivalents filed in other jurisdictions, potentially affecting enforcement or licensing strategies.

Competing Patents

  • The region hosts multiple patents targeting similar drug classes, often with overlapping claims on formulations or methods.
  • Prior art includes older patents and publications from public research entities, suggesting potential for validity challenges.

Patent Litigation and Enforcement

  • Limited enforcement actions reported in Argentina for pharmaceuticals of similar scope.
  • Patent validity may be challenged based on prior art or obviousness, especially if claims are narrow.

Patent Filing Trends

  • Argentina has seen an increase in pharmaceutical patent filings post-2010.
  • Filing strategies often involve narrow claims to avoid prior art obstacles.

Regulatory Context

  • Patent protection is coupled with regulatory approvals from ANMAT.
  • Patent term extensions are not standard in Argentina but could impact exclusivity duration.

Comparative Analysis

Aspect Argentina Patent AR107965 Similar Patents in Region International Practice
Claim Breadth Narrow; specific formulations Broader claims on active ingredients Broader claims on therapeutic uses or delivery methods
Enforcement Limited publicly available data Active in some jurisdictions Enforcement varies; depends on claim scope
Patent Term 20 years from filing Standard 20 years from earliest priority

Implications for R&D and Commercialization

  • Narrow claims limit infringement risks but reduce licensing scope.
  • The patent's specificity demands precise licensing strategies.
  • Potential to pursue patent term extensions or obtain supplementary new data to strengthen claims.

Summary of Key Data

  • Patent Number: AR107965
  • Filing Date: Not specified; likely in early 2010s
  • Grant Date: Not specified; typically 3–5 years post-filing
  • Claims Type: Narrow (composition and method specific)
  • Patent Life: 20 years from filing

Key Takeaways

  • AR107965 protects a specific drug formulation and method, limiting its enforcement to precise embodiments.
  • Its narrow scope may hinder broader licensing or patentability challenges to competitors.
  • The patent landscape in Argentina aligns with regional trends toward narrow claims and strategic filings.
  • Enforcement activity appears limited; validation depends on ongoing patent validity challenges.
  • Parallel patent filings in other regions could influence licensing or legal strategies.

FAQs

  1. Does AR107965 cover all formulations of the active ingredient? No. The claims focus on specific formulations and methods, not all possible variations.

  2. Can competitors develop alternative formulations without infringing? Yes, if those formulations fall outside the scope of the claims.

  3. Has AR107965 faced validity challenges? There are no publicly available records; validity may be contested based on prior art.

  4. Is there potential for patent term extension? Argentina generally does not offer patent term extensions; exclusivity depends solely on patent duration.

  5. How does the patent landscape affect market entry? Narrow claims and regional patent filings require precise freedom-to-operate analyses to avoid infringement.


References

[1] Argentine Patent Office. (2022). Patent Database.

[2] World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports.

[3] Argentine Intellectual Property Law. (1996). Ley de Patentes.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.